Genentech

PULMOZYME

  1. Home
  2.  / 
  3. J Code
  4.  / PULMOZYME – J7639

Manufacturer:

Genentech

Name:

PULMOZYME

HCPCS Code Descriptor:

Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Category:

J Code

HCPCS:

J7639

NDC(s):

50242-0100-40

Primary Type:

Pulmonary

Generic Status:

Single-Source

Route of Administration:

Inhalation

About:

PULMOZYME is a Pulmonary drug manufactured by Genentech and administered via the Inhalation route of administration. The J Code: J7639 is aligned to the drug PULMOZYME.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/00

HCPCS Effective Date:

1/1/09

HCPCS Short Description:

Dornase alfa non-comp unit

Billing and Coding Guide:

https://www.pulmozyme.com/content/dam/gene/accesssolutions/pdfs/coding/Pulmozyme-Billing-Coding-for-Cystic-Fibrosis.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation